Concentra Group Holdings Parent, Inc. (CON)
NYSE: CON · Real-Time Price · USD
23.45
-0.11 (-0.47%)
At close: Mar 5, 2026, 4:00 PM EST
23.43
-0.02 (-0.09%)
Pre-market: Mar 6, 2026, 7:15 AM EST

Company Description

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States.

The company operates in three segments: Occupational Health centers, Onsite health clinics, and Other business.

It offers occupational health services, including workers compensation, employer, and consumer health services; and employer-sponsored primary care services at workplace, including mobile health and episodic specialty testing services.

It also operates Concentra Telemed, a telemedicine platform for the treatment of work-related injuries and illnesses; Concentra Pharmacy for distributing repackaged medications; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces.

In addition, the company provides injury care, primary care, urgent care, preventive care, clinical testing, physical examinations and evaluations, drug and alcohol screenings, clinical testing, vaccinations and other preventive care, and a range of consultative services designed to protect employees from workplace hazards.

The company was founded in 1979 and is based in Addison, Texas.

Concentra Group Holdings Parent, Inc.
Concentra Group Holdings Parent logo
Country United States
Founded 1979
IPO Date Jul 25, 2024
Industry Medical Care Facilities
Sector Healthcare
Employees 9,999
CEO William Newton

Contact Details

Address:
5080 Spectrum Drive, Suite 1200W
Addison, Texas 75001
United States
Phone 972 364 8000
Website concentra.com

Stock Details

Ticker Symbol CON
Exchange NYSE
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $23.50
CIK Code 0002014596
CUSIP Number 20603L102
ISIN Number US20603L1026
Employer ID 30-1006613
SIC Code 8093

Key Executives

Name Position
William Keith Newton Chief Executive Officer and Director
Matthew T. DiCanio M.B.A. President and Chief Financial Officer
John A. deLorimier Executive Vice President and Chief Information and Technology Officer
Dr. John R. Anderson DO, FACOEM Executive Vice President and Chief Medical Officer
Michael A. Kosuth Executive Vice President and Chief Operating Officer of East
Timothy F. Ryan Executive Vice President and Chief Legal Counsel
Thomas A. Devasia Executive Vice President and Chief Marketing and Innovation Officer
Danielle Kendall Executive Vice President and Chief People Officer
Giovanni Gallara Executive Vice President and Chief Clinical Services Officer
Douglas R. McAndrew Executive Vice President and Chief Operating Officer of West

Latest SEC Filings

Date Type Title
Feb 26, 2026 10-K Annual Report
Feb 26, 2026 8-K Current Report
Feb 17, 2026 SCHEDULE 13G/A Filing
Jan 28, 2026 8-K Current Report
Jan 12, 2026 8-K Current Report
Nov 26, 2025 SCHEDULE 13D/A Filing
Nov 14, 2025 SCHEDULE 13G/A Filing
Nov 14, 2025 SCHEDULE 13G/A Filing
Nov 10, 2025 8-K Current Report
Nov 6, 2025 10-Q Quarterly Report